Skip to main content
. 2023 Aug 16;8(34):31305–31317. doi: 10.1021/acsomega.3c03762

Table 2. EIS Results in CO2–Saturated Solution without and with an Inhibitor.

      CPEf
  CPEdl
       
inhibitor C (ppm) Rs (Ω·cm2) Y0–1 cm–2 Sn) n Rf (Ω·cm2) Y0–1 cm–2 sn) n Rct (Ω·cm2) Rp (Ω·cm2) ηz% χ2 × 10–4
blank 0 61.5 ± 1.2 1.7 ± 0.1 × 10–4 0.86 ± 0.05 3.3 ± 1.5 1.3 ± 0.5 × 10–4 0.84 ± 0.11 136.0 ± 6.5 139.3 ± 4.7   1.36
2-FFT 1.0 62.8 ± 5.6 7.4 ± 0.2 × 10–5 0.89 ± 0.01 67.6 ± 12.8 1.4 ± 0.2 × 10–4 0.76 ± 0.20 302.4 ± 14.1 370.0 ± 13.6 62.4 1.35
2.5 59.4 ± 7.9 1.1 ± 0.3 × 10–4 0.86 ± 0.02 268.9 ± 43.8 3.0 ± 1.0 × 10–4 0.84 ± 0.09 477.8 ± 25.7 746.7 ± 33.8 81.3 2.21
5.0 62.7 ± 2.6 1.2 ± 0.5 × 10–4 0.86 ± 0.03 278.3 ± 55.7 1.4 ± 0.5 × 10–4 0.84 ± 0.10 750.6 ± 55.1 1028.9 ± 55.5 86.5 2.27
7.5 63.3 ± 2.4 3.2 ± 0.2 × 10–4 0.76 ± 0.15 1467.0 ± 237.0 8.9 ± 0.4 × 10–4 1.00 ± 0.00 109.2 ± 12.5 1576.2 ± 100.8 91.2 1.14
10.0 63.8 ± 5.5 1.4 ± 0.1 × 10–4 0.85 ± 0.04 1481.0 ± 158.5 1.7 ± 0.2 × 10–4 0.93 ± 0.04 1311.0 ± 264.6 2792.0 ± 208.4 95.0 2.71
DFDS 1.0 60.7 ± 6.3 8.6 ± 0.6 × 10–5 0.90 ± 0.01 478.1 ± 51.7 2.1 ± 0.7 × 10–4 0.70 ± 0.28 797.5 ± 36.4 1275.6 ± 47.5 89.1 2.19
2.5 60.6 ± 7.4 1.2 ± 0.2 × 10–4 0.88 ± 0.02 1120.0 ± 100.0 1.8 ± 0.5 × 10–4 0.79 ± 0.19 2071.0 ± 147.8 3191.0 ± 125.8 95.6 2.63
5.0 60.6 ± 8.5 4.6 ± 0.4 × 10–5 0.90 ± 0.02 2088.0 ± 217.7 1.3 ± 0.5 × 10–4 0.79 ± 0.14 2674.0 ± 124.3 4762.0 ± 187.1 97.1 1.61
7.5 56.9 ± 7.8 3.0 ± 0.2 × 10–5 0.92 ± 0.01 4791.0 ± 259.3 1.2 ± 0.1 × 10–4 0.86 ± 0.08 1996.0 ± 210.2 6787.0 ± 233.7 97.9 2.17
10.0 59.5 ± 6.1 2.6 ± 0.1 × 10–5 0.91 ± 0.02 5715.0 ± 184.8 5.3 ± 0.2 × 10–5 0.72 ± 0.22 1843.0 ± 117.1 7558.0 ± 174.7 98.2 1.38